Core Viewpoint - Shanghai Zhaoxin Integrated Circuit Co., Ltd. has submitted an IPO application to the Sci-Tech Innovation Board, aiming to raise 4.169 billion yuan [1] Company Overview - Zhaoxin Integrated focuses on the research, design, and sales of high-end general-purpose processors and supporting chips, with main products including the "Kaixian" series desktop processors and "Kaisheng" series server processors [1] - The company has made significant progress in expanding its market presence in the medical industry, successfully winning a bid for over 6,000 medical desktop PCs for a major hospital, competing against Intel and AMD [1] Industry Context - The medical industry is undergoing a digital transformation, with plans to significantly enhance the upgrade ratio of core information systems in hospitals by the end of 2025, despite facing challenges such as ecosystem fragmentation and system compatibility [1] - In response, Zhaoxin Integrated has introduced platforms like "seamless migration" and "one-stop support," collaborating with ecosystem partners to establish a Medical Application Innovation Center, providing comprehensive selection guidance from chips to operating systems and application software [1] Partnerships and Collaborations - Zhaoxin Integrated has nearly 4,000 ecosystem partners in system integration, software, and hardware, and has collaborated with major domestic operating system vendors such as Kirin Software Co., Ltd., Tongxin Software Technology Co., Ltd., and Zhongke Fangde Software Co., Ltd. to complete over 200,000 software and hardware adaptation and product optimization projects [1]